Bearish signal on daily chart
Company has spent 4.55% of its operating revenues towards interest expenses and 13.58% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Potential
Upside
1 Year
Target
BUY
Mean Recos by
7 Analysts
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
Company has spent 4.55% of its operating revenues towards interest expenses and 13.58% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Black Marubozu(s) was formed for Rainbow Childrens
Rainbow Childrens Medicare Ltd. share price moved down by -1.40% from its previous close of Rs 1,387.20. Rainbow Childrens Medicare Ltd. stock last traded price is 1,367.80
Share Price | Value |
---|---|
Today/Current/Last | 1,367.80 |
Previous Day | 1,387.20 |
PE Ratio (x) | 58.01 | ||||||||||
EPS - TTM (₹) | 23.44 | ||||||||||
MCap (₹ Cr.) | 13,810.01 | ||||||||||
Sectoral MCap Rank | 10 | ||||||||||
PB Ratio (x) | 10.92 | ||||||||||
Div Yield (%) | 0.22 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 1,378.46 | ||||||||||
52W H/L (₹) |
1 Day | -1.4% |
1 Week | 1.81% |
1 Month | -9.55% |
3 Months | 5.61% |
1 Year | 1.47% |
3 Years | 213.32% |
5 Years | N.A. |
Negative Breakout on April 28: 5 stocks cross below their 200 DMAs
Ahead of Market: 10 things that will decide stock market action on Thursday
Positive Breakout: These 4 stocks cross above their 200 DMAs
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
AnnouncementsCurrent
Mean Recos by 7 Analysts
That's all for Rainbow Childrens recommendations. Check out other stock recos.
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 7 | 7 | 7 | 7 |
Employee & Interest Expense
Company has spent 4.55% of its operating revenues towards interest expenses and 13.58% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)Quarterly | Annual | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|---|
Total Income | 411.36 | 428.73 | 342.15 | 353.88 | 344.57 |
Total Income Growth (%) | -4.05 | 25.31 | -3.31 | 2.70 | 1.20 |
Total Expenses | 298.96 | 305.28 | 270.64 | 267.86 | 245.54 |
Total Expenses Growth (%) | -2.07 | 12.80 | 1.04 | 9.09 | 1.50 |
EBIT | 112.40 | 123.45 | 71.52 | 86.02 | 99.03 |
EBIT Growth (%) | -8.96 | 72.63 | -16.86 | -13.13 | 0.45 |
Profit after Tax (PAT) | 68.69 | 78.87 | 39.53 | 50.97 | 62.13 |
PAT Growth (%) | -12.91 | 99.50 | -22.44 | -17.95 | -1.24 |
EBIT Margin (%) | 27.32 | 28.80 | 20.90 | 24.31 | 28.74 |
Net Profit Margin (%) | 16.70 | 18.40 | 11.55 | 14.40 | 18.03 |
Basic EPS (₹) | 6.76 | 7.77 | 3.89 | 5.02 | 6.12 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|
Total Assets | 2,170.40 | 1,776.30 | 1,295.75 |
Total Assets Growth (%) | 22.19 | 37.09 | 19.84 |
Total Liabilities | 905.48 | 711.39 | 689.48 |
Total Liabilities Growth (%) | 27.28 | 3.18 | 8.94 |
Total Equity | 1,264.92 | 1,064.92 | 595.32 |
Total Equity Growth (%) | 18.78 | 78.88 | 36.09 |
Current Ratio (x) | 4.16 | 3.35 | 2.32 |
Total Debt to Equity (x) | 0.00 | 0.00 | 0.07 |
Contingent Liabilities | 61.73 | 48.03 | 60.42 |
All figures in Rs Cr, unless mentioned otherwise
Decrease in Cash from Investing
Company has used Rs 226.47 cr for investing activities which is an YoY decrease of 51.32%. (Source: Consolidated Financials)Annual | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|
Net Cash flow from Operating Activities | 321.40 | 327.23 | 223.73 |
Net Cash used in Investing Activities | -226.47 | -465.20 | -175.35 |
Net Cash flow from Financing Activities | -101.78 | 143.41 | -44.06 |
Net Cash Flow | -6.85 | 5.43 | 4.32 |
Closing Cash & Cash Equivalent | 10.12 | 15.41 | 9.98 |
Closing Cash & Cash Equivalent Growth (%) | -34.33 | 54.42 | 76.37 |
Total Debt/ CFO (x) | 0.00 | 0.00 | 0.19 |
All figures in Rs Cr, unless mentioned otherwise
Annual | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|
Return on Equity (%) | 17.23 | 19.89 | 23.36 |
Return on Capital Employed (%) | 17.50 | 20.64 | 20.54 |
Return on Assets (%) | 9.99 | 11.86 | 10.67 |
Interest Coverage Ratio (x) | 7.89 | 7.74 | 6.09 |
Asset Turnover Ratio (x) | 0.66 | 0.76 | 0.82 |
Price to Earnings (x) | 60.98 | 35.21 | - |
Price to Book (x) | 10.47 | 6.99 | - |
EV/EBITDA (x) | 28.27 | 17.25 | - |
EBITDA Margin (%) | 35.92 | 36.40 | 33.25 |
Bullish / Bearish signals for Rainbow Childrens basis selected technical indicators and moving average crossovers.
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on:
Choose from Peers
Choose from Stocks
MF Ownership details are not available.
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
Apr 04, 2025 | Mar 03, 2025 | POM | - |
Feb 09, 2025 | Feb 03, 2025 | Board Meeting | Quarterly Results & Others |
Oct 27, 2024 | Oct 21, 2024 | Board Meeting | Quarterly Results |
Aug 13, 2024 | Aug 05, 2024 | Board Meeting | Quarterly Results |
Jul 30, 2024 | May 21, 2024 | AGM | - |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Final | 30% | 3.0 | Jul 23, 2024 | May 21, 2024 |
Final | 30% | 3.0 | Jun 22, 2023 | May 15, 2023 |
Final | 20% | 2.0 | Sep 07, 2022 | May 27, 2022 |
No other corporate actions details are available.
Rainbow Childrens Medicare Ltd., incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 13,810.01 Crore) operating in Hospitals & Allied Services sector. Rainbow Childrens Medicare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Services (Medical) and Other Operating Revenue for the year ending 31-Mar-2024. Show More
Ramesh Kancharla
Chairman & Managing DirectorDinesh Kumar Chirla
Whole Time DirectorAdarsh Kancharla
Non Executive DirectorAluri Srinivasa Rao
Independent DirectorIndustry
Key Indices Listed on
Nifty 500, BSE 500, BSE 250 SmallCap Index, + 11 more
Address
8-2-120/103/1,Survey No. 403,Hyderabad, Telangana - 500034
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.